TRAIDIT THIANTHANYAKIJ

Dr. TRAIDIT THIANTHANYAKIJ

Tongji Hospital, School of Medcine, Tongji University, Shanghai, China
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
YZYinghui Zhou
Yinghui Zhou
QLQingmei Liu
Qingmei Liu
YBYanshuang Bai
Yanshuang Bai
KYKai Yang
Kai Yang
YYYaqi Ye
Yaqi Ye
WWWenyu Wu
Wenyu Wu

1 April 2024 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
TTTRAIDIT THIANTHANYAKIJ
TRAIDIT THIANTHANYAKIJ
YZYinghui Zhou
Yinghui Zhou
MWMengyi Wu
Mengyi Wu
YZYuting Zhang
Yuting Zhang
JLJui-Ming Lin
Jui-Ming Lin
WWWenyu Wu
Wenyu Wu
Background: Existing research links oxidative stress and inflammation to hair loss. Salvianolic acid B (SAB) is known for its anti-oxidative, anti-inflammatory, and other beneficial pharmacological properties. Objective: To assess the efficacy of SAB in modulating hair growth. Methods: In vivo experiments were conducted using C57BL/6 mice to evaluate the effects of SAB on hair and skin parameters. The study involved ex vivo analysis of human hair follicles (HFs) for hair shaft length and hair growth cycle assessment. In vitro, human dermal papilla cells (hDPCs) were cultured with SAB, and their proliferation, protection against H2O2-induced oxidative damage, and gene/protein expression alterations were examined using various analytical techniques, including Real-Time Cell Analysis (RTCA), DCFH-DA Assay, RNA-seq, and KEGG pathway analysis. Results: SAB treatment in mice significantly improved hair growth and vascularization by day 21. In human HFs, SAB extended hair shaft length and delayed the transition to the catagen phase. SAB-treated hDPCs showed a notable decrease in the expression of oxidation-antioxidation-related genes and proteins, including reduced phosphorylation levels of ERK and p38. Conclusion: The study indicates that SAB promotes hDPC proliferation and offers protection against oxidative stress, highlighting its potential as a therapeutic agent for enhancing hair growth and treating hair loss.

27 July 2026 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
HDHuiling Deng
Huiling Deng
KDKimhong Deab
Kimhong Deab
TTTRAIDIT THIANTHANYAKIJ
TRAIDIT THIANTHANYAKIJ
LTLin Tao
Lin Tao
HCHaiyan Cui
Haiyan Cui

9 December 2025 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
HDHuiling Deng
Huiling Deng
LSLishuai Shi
Lishuai Shi
TTTRAIDIT THIANTHANYAKIJ
TRAIDIT THIANTHANYAKIJ
GWGuobao Wang
Guobao Wang
HCHaiyan Cui
Haiyan Cui

2 July 2024 in Medicine: Case Reports and Study Protocols
Verified
Journal Article
Open access
YJYuan Jiang
Yuan Jiang
CSChinnawut Suriyonplengsaeng
Chinnawut Suriyonplengsaeng
MWMengyi Wu
Mengyi Wu
JLJinran Lin
Jinran Lin
QLQingmei Liu
Qingmei Liu
TTTRAIDIT THIANTHANYAKIJ
TRAIDIT THIANTHANYAKIJ
Rationale: Xanthelasma, characterized by yellowish plaques around the eyelids due to lipid deposits, is typically treated through invasive methods like laser therapy or surgery, which often leads to scarring and dyspigmentation. This case series investigates the potential of Zhuang medicine medicated thread moxibustion as a less invasive alternative. Patient Concerns: Three female patients, aged 34, 45, and 55, presented with non-tender, soft yellow plaques near the medial canthi of both upper eyelids. The lesions varied in size and had been present for durations ranging from 6 months to 2 years. These patients expressed concerns about the pain and potential adverse reactions associated with conventional treatments, opting instead for an alternative approach. Diagnoses: Each patient was diagnosed with xanthelasma based on clinical evaluation. Standard diagnostic tests returned normal results, confirming the absence of underlying systemic issues. Interventions: The treatment regimen involved Zhuang medicine medicated thread moxibustion applied at 10-day intervals for a total of three sessions. This traditional method was selected due to its minimally invasive nature. Outcomes: After the first session, patients experienced mild edema, which resolved within 24 h. A significant reduction in the size of the plaques was observed after the second session, and by the third session, there was complete resolution of the plaques. Throughout the treatment and follow-up period of 3 months, no adverse reactions or recurrence of the xanthelasma was noted. Lessons: This case series suggests that Zhuang medicine medicated thread moxibustion could be a safe and effective alternative for the treatment of xanthelasma, avoiding the complications associated with more invasive conventional methods. Further research involving larger sample sizes is recommended to validate these preliminary findings and possibly integrate this method into broader clinical practice.